See also this year's filing and all EDGAR filings for this company.
PDF Report 0001042074_2023_Cymabay_Therapeutics_Inc.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001042074, Cymabay Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 138,073,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 701,000 |
| 3 | remainder_Assets | 3,078,000 |
| 4 | LiabilitiesCurrent | 15,441,000 |
| 5 | LiabilitiesNoncurrent | 30,000 |
| 6 | remainder_Liabilities | 90,227,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 25,403,446 |
| 9 | ResearchAndDevelopmentExpense | 67,496,277 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -11,805,491 |
| 13 | remainder_ComprehensiveNetIncome | -158,525 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 141,852,000 |
| 1 | Liabilities | 105,698,000 |
| 2 | Expenses | 92,899,723 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 36,154,000 |
| 5 | NetIncome | -104,705,214 |
| 6 | ComprehensiveNetIncome | -104,784,476 |
| 7 | BaseVar | 176,206,870 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.210 |
| 9 | EconomicCapitalRatio | 1.41 |